Concentra Group Holdings Parent, Inc. logo

Concentra Group Holdings Parent, Inc.(CON)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
4-STAR RATING
STRONG BUY
BUY for 133 days
PROFIT SINCE LAST BUY
+81.06% ▲
LAST CLOSE
$42.55
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CON

11/13/2026: CON (4-star) is a STRONG-BUY. BUY for 133 days. Simulated Profits (81.06%). Updated daily EoD!

Concentra Group Holdings Parent, Inc. is a leading provider of occupational medicine, urgent care, and physical therapy services, operating an extensive network of clinics across the United States. Its primary business strength lies in its specialized clinical focus and deep-rooted relationships with major corporate employers. While the company has a leading position in occupational health, it faces risks related to economic sensitivity and intense competition from broader healthcare systems. The investment story centers on the growing demand for outpatient services, though potential investors should monitor execution risks and margin pressure from labor costs. Currently, it is a company with a focused service niche, suitable for those looking for exposure to clinical service delivery.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitOffers growth potential in outpatient services but faces execution risks in a competitive landscape.
Momentum investorWeak fitMomentum profile is currently neutral pending sustained positive price action post-IPO.
Value investorMixed fitValuation assessment requires further public trading history to establish a long-term baseline.
Dividend investorWeak fitThe company is in an early phase post-IPO with no established dividend track record.
Low-risk investorWeak fitHealthcare services entail regulatory and operational risks unsuitable for highly risk-averse portfolios.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highRecent IPO status often leads to increased price sensitivity.
Valuation riskMediumEstablishing a fair market value is challenging for newly listed entities.
Competition risk (urgent care/occupational health)HighThe sector faces intense competition from established hospital networks.
Business qualityMediumWhile operationally stable, the business is sensitive to economic and employment cycles.
Dividend incomeLow / noneNo current dividend policy exists for income-seeking investors.
Execution riskMediumScaling a large physical footprint requires consistent management of clinical and labor costs.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 5.40B USD
Price to earnings Ratio 25.44
1Y Target Price 45.9
Price to earnings Ratio 25.44
1Y Target Price 45.9
Volume (30-day avg) 1.2M shares
Beta 0.51
52 Weeks Range 18.77 - 44.22
Updated Date 11/13/2026
52 Weeks Range 18.77 - 44.22
Updated Date 11/13/2026
Dividends yield (FY) 0.58%
Basic EPS (TTM) 1.69

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit 29.28%
Avg. Invested days 44
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
CON receives a 4-star rating, supported by solid company fundamentals, solid quantitative characteristics, and solid analyst coverage. The rating is constrained by limited analyst upside.

Company Fundamentals

★★★★★
CON has solid overall fundamentals (4 stars), with moderate financial health, moderate growth momentum, and strong ownership. In FY2025 versus FY2024, solid cash generation (FCF margin 9.1%) and solid revenue growth (+13.9%) are partially offset by slightly negative earnings growth (-0.1%), soft profitability (net margin 7.7%).

Financial Health Rating

★★★★★
CON's financial health is supported by solid cash strength, including free-cash-flow generation (9.1% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is CON's strongest growth driver at +13.9% FY2025 versus FY2024 (solid, 4 stars). By comparison, while earnings growth (-0.1%, slightly negative) and free-cash-flow growth (-6.3%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 92.2% and approximately 90.3% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 8.80% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 13.92%
T. Rowe Price Associates, Inc. 13.89%
Vanguard Portfolio Management, LLC 5.35%
Vanguard Capital Management, LLC 4.02%
State Street Corp 3.80%

Unit Economics (Per $1K Revenue)

★★★★★
CON generates approximately $283 of gross profit, $154 of operating income, and $91 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins and solid cash conversion support a 3-star rating, while capital efficiency is moderate.

Economic Dimensions

★★★★★
Effective Tax Rate: 22.78%

Quantitative Style Profile

★★★★★
CON has a high-quality, liquid, relatively low-volatility profile. Valuation that is moderately attractive rather than deeply discounted is the primary drawback.

Style Classification

Quality Focused

Quality TiltLow VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Occupational MedicineInjury care, drug testing, and employee physicals for corporate clients.The primary engine of revenue, driven by employer-mandated health requirements.
Physical TherapyOutpatient rehabilitation services.Supports recovery services often paired with injury treatment.
Urgent CareGeneral walk-in medical services.Provides additional volume and revenue from the general public.

Earnings Date

Report Date 2026-11-05
When After Market
Estimate 0.45
Actual 0.52

Profitability

Profit Margin 9.26%
Operating Margin (TTM) 17.15%

Management Effectiveness

Return on Assets (TTM) 8.55%
Return on Equity (TTM) 47.22%

Valuation

Trailing PE 25.44
Forward PE 22.52
Enterprise Value 7.45B
Price to Sales(TTM) 2.31
Enterprise Value 7.45B
Price to Sales(TTM) 2.31
Enterprise Value to Revenue 3.21
Enterprise Value to EBITDA 15.78
Shares Outstanding 125.72M
Shares Floating 113.57M
Shares Outstanding 125.72M
Shares Floating 113.57M
Percent Insiders 8.8
Percent Institutions 92.16

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.